What is Psychemedics?
Psychemedics, founded in 1986, is a prominent provider of hair testing technology for drug detection. The company's patented drug testing processes are widely adopted for pre-employment and random drug screening across diverse sectors, including corporate clients, law enforcement, financial institutions, and educational organizations. Psychemedics distinguishes itself through its commitment to research and development, offering advanced alternatives to conventional testing methodologies in the specialized field of substance abuse detection.
How much funding has Psychemedics raised?
Psychemedics has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Psychemedics
PPP
Public-Private Partnership
What's next for Psychemedics?
The recent strategic investment signals a phase of significant growth and potential expansion for Psychemedics. This capital infusion is likely to fuel further research and development into innovative drug detection technologies, potentially broadening the company's market reach and enhancing its service offerings. The company's focus on patented processes and its established presence in critical sectors suggest a trajectory aimed at solidifying its leadership in the drug testing industry.
See full Psychemedics company page
